Page 6 - Devika Syamnath News Today

Swedish electric-vehicle maker Polestar Automotive will delay the publication of its fourth-quarter and full-year 2023 financial results for a second time, a spokesperson for the company said on...

Polestar did not provide a date for the release but said it still intends to publish first-quarter financial results on May 23. The delay is partly because the company needs more time to finalize its financial statements over accounting misstatements in 2021 and 2022 that will be rectified in the 2023 report. Polestar also requires more time to complete work related to the internal control of its financial reporting as per the Sarbanes-Oxley Act of 2002, the spokesperson said.

Investors who bet against Tesla stock have lost $5.5 billion in the four sessions since the electric car maker promised more affordable cars, according to data from S3 Partners. The...

(Reuters) -U.S. stock index futures edged higher on Monday as Tesla and Apple led gains in megacap companies, while investors exercised caution ahead of the Federal Reserve's interest rate decision later in the week. Apple added 2% after a report that the iPhone maker had renewed discussions with OpenAI about using the startup's generative artificial intelligence (AI) technology. Focus will now shift to the Fed's interest rate decision due on Wednesday, ahead of a key jobs repor...

Wall Streets main indexes opened higher on Monday as Tesla and Apple led gains in megacap companies, while investors exercised caution ahead of the Federal Reserves interest rate decision later in... -April 29, 2024 at 09:33 am EDT - MarketScreener

April 26 - Intel shares slumped more than 7% premarket on Friday after a downbeat second-quarter sales forecast signaled that the boom in AI technology was diverting...

(Reuters) -AbbVie raised its annual profit forecast on Friday after strong sales of its immunology drug Skyrizi and cancer drug Imbruvica helped the company beat Wall Street estimates for the first quarter. The company now expects adjusted profit of between $11.13 and $11.33 per share for this year, compared with $10.97 to $11.17 estimated earlier. Analysts on average expect annual profit of $11.10 per share, according to LSEG data.

AbbVie raised its annual profit forecast on Friday after strong sales of its immunology drug Skyrizi and cancer drug Imbruvica helped the company beat Wall Street estimates for the first quarter. ...

Royal Caribbean Group on Thursday raised its annual profit forecast for a second time, benefiting from record demand for cruises and robust on-board spending. It now expects annual...

Shares of International Business Machines fell more than 8% in premarket trading on Thursday, as its consulting business faces pressure from enterprises tightening their budgets to cope with an...